Chemed (NYSE:CHE) Upgraded to “Strong-Buy” at Wall Street Zen

Wall Street Zen upgraded shares of Chemed (NYSE:CHE) from a hold rating to a strong-buy rating in a research report report published on Saturday.

CHE has been the subject of a number of other reports. Bank of America restated a “neutral” rating on shares of Chemed in a research note on Wednesday. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Royal Bank Of Canada upped their price target on shares of Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research report on Thursday. Finally, Oppenheimer increased their price objective on shares of Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a report on Friday. One analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $530.75.

Chemed Stock Performance

Shares of CHE stock opened at $533.03 on Friday. The company has a market cap of $7.07 billion, a P/E ratio of 26.77, a PEG ratio of 2.02 and a beta of 0.52. The business has a 50 day moving average of $467.11 and a two-hundred day moving average of $436.57. Chemed has a 52 week low of $365.20 and a 52 week high of $551.68. The company has a quick ratio of 0.83, a current ratio of 0.91 and a debt-to-equity ratio of 0.17.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, topping analysts’ consensus estimates of $5.60 by $0.46. The business had revenue of $673.25 million for the quarter, compared to analysts’ expectations of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business’s quarterly revenue was up 8.8% on a year-over-year basis. During the same period in the prior year, the firm earned $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, analysts anticipate that Chemed will post 23.18 EPS for the current year.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Thursday, May 28th were paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Thursday, May 28th. Chemed’s payout ratio is currently 12.05%.

Insiders Place Their Bets

In related news, Director Andrea R. Lindell sold 1,347 shares of the company’s stock in a transaction dated Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the sale, the director owned 4,578 shares of the company’s stock, valued at $2,047,876.74. This represents a 22.73% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 3.33% of the stock is owned by insiders.

Institutional Trading of Chemed

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Legacy Wealth Asset Management LLC raised its holdings in Chemed by 25.8% during the second quarter. Legacy Wealth Asset Management LLC now owns 3,056 shares of the company’s stock worth $1,423,000 after purchasing an additional 626 shares in the last quarter. Sunburst Financial Group LLC lifted its position in Chemed by 12.0% in the second quarter. Sunburst Financial Group LLC now owns 812 shares of the company’s stock worth $378,000 after purchasing an additional 87 shares during the period. First Heartland Consultants Inc. boosted its stake in Chemed by 14.5% during the 2nd quarter. First Heartland Consultants Inc. now owns 1,404 shares of the company’s stock valued at $654,000 after purchasing an additional 178 shares in the last quarter. GAMMA Investing LLC boosted its stake in Chemed by 149.0% during the 2nd quarter. GAMMA Investing LLC now owns 620 shares of the company’s stock valued at $289,000 after purchasing an additional 371 shares in the last quarter. Finally, Somerset Trust Co acquired a new position in shares of Chemed during the 2nd quarter valued at $228,000. 95.85% of the stock is currently owned by institutional investors.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.